Two vs three cycles of neoadjuvant sintilimab plus chemotherapy for resectable non-small-cell lung cancer: neoSCORE trial.

Details

Language :

English

ISSN :

20959907

Volume :

8

Issue :

1

Database :

Complementary Index

Journal :

Signal Transduction & Targeted Therapy

Publication Type :

Academic Journal

Accession number :

162992756

Full Text :

https://doi.org/10.1038/s41392-023-01355-1